출판 : MarketsandMarkets（마켓츠앤드마켓츠）출판년월 : 2021년12월
・용도 [임상 시험(임신, 감염증(모기, 인플루엔자, STI, 간염, TB) 심장 마커 지질 시험) 수의사, 식품 안전], 제품(리더, 키트), 기술, 최종 사용자 – 2026년까지의 세계 예측
Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety) Product (Readers, Kits) Technique, End User – Global Forecast to 2026
| 페이지수 | 376 |
| 도표수 | 422 |
| 구성 | 영문조사보고서 |
| 가격 |
The global lateral flow assays market is projected to reach USD 11.4 billion by 2026 from USD 9.6 billion in 2021, at a CAGR of 3.4% during the forecast period. The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market. On the other hand, reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key restraints.
전 세계 측면 유동 분석 시장은 예측 기간 동안 CAGR 3.4%로 2021년 96억 달러에서 2026년 114억 달러에 이를 것으로 예상됩니다. 전 세계적으로 전염병의 높은 유병률, 노인 인구의 급속한 성장, 현장 진료 테스트에 대한 수요 증가, 가정 기반 측면 흐름 분석 장치의 사용 증가가 이 시장의 성장을 이끄는 주요 요인입니다. 반면에 기존 진단 절차를 변경하는 것을 꺼리는 의사와 환자와 측방 흐름 분석의 낮은 정확도가 주요 제약 사항입니다.
“Kits & Reagents segment accounted for the largest share in the lateral flow assays market.”
“키트 및 시약 부문은 측면 유동 분석 시장에서 가장 큰 점유율을 차지했습니다.”
Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. In 2020, kits & reagents accounted for the larger share of 87.5% of the global lateral flow assays market. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for POC testing, the growing burden of chronic diseases, the increasing use of lateral flow kits in home care, and their convenience and ease of use. The lateral flow readers segment is bifurcated into digital/handheld readers and benchtop readers. This segment is expected to grow at a higher CAGR of 7.1% during the forecast period.
“Clinical Testing segment is expected to witness the fastest growth in the forecast period.”
Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of 89.3% of the lateral flow assays market in 2020. The large share of this segment can be attributed to the rising prevalence of chronic diseases, growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.
“Sandwich assays technique accounted for the largest share of lateral flow assays market in 2020”
Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The sandwich assays technique dominated the lateral flow assays market with a share of 70.9% in 2020. The large share of this segment can be attributed to its better assay sensitivity and specificity and its extensive applications in the measurement of critical analytes (such as cardiac and hepatitis markers).
“Blood samples accounted for the largest share of lateral flow assays market in 2020”
Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Blood samples accounted for the largest market share of 55.9% in 2020. The use of blood samples in lateral flow tests for infectious diseases such as malaria, HIV, and syphilis; the rising awareness of rapid testing solutions; and easy detection of disease antibodies from blood samples are key factors driving the growth of this segment.
“The hospitals & Clinics segment accounted for the largest share of lateral flow assays market in 2020”
Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment accounted for the largest market share of 37.6% in 2020. Technological advancements, the increasing adoption of point-of-care testing and growing patient inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment. The COVID-19 pandemic has also increased the demand for point-of-care testing in professional healthcare settings, further driving the growth of this market in the forecast period.
“North America accounted for the largest share of the lateral flow assays market in 2020”
The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 38.8% of the lateral flow assays market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. However, the APAC is expected to grow at the highest CAGR of 5.8% during the forecast period. The rapidly developing healthcare industry in China and India, growth in the aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for home and POC testing are supporting market growth in the APAC. The current COVID-19 scenario and its high impact in the Asia Pacific (especially India) have also resulted in a high growth rate in the lateral flow assays market in this region.
A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
• By Designation: C-level–45%, Director Level–25%, and Others–30%
• By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).
Research Coverage:
The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
목차
1 INTRODUCTION 48
1.1 OBJECTIVES OF THE STUDY 48
1.2 MARKET DEFINITION 48
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE LATERAL FLOW ASSAYS MARKET 48
1.3 MARKET SCOPE 49
1.3.1 MARKETS COVERED 49
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION 49
FIGURE 2 LATERAL FLOW ASSAYS MARKET, BY REGION 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 50
1.4 CURRENCY 51
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 51
1.5 STAKEHOLDERS 51
1.6 SUMMARY OF CHANGES 51
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH APPROACH 53
FIGURE 3 RESEARCH DESIGN 53
2.1.1 SECONDARY DATA 53
2.1.1.1 Key data from secondary sources 54
2.1.2 PRIMARY DATA 55
2.1.2.1 Primary sources 55
2.1.2.2 Key data from primary sources 56
2.1.2.3 Breakdown of primaries 56
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 56
2.2 MARKET SIZE ESTIMATION 57
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020) 58
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2020) 58
FIGURE 7 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON THE MALARIA LATERAL FLOW TESTING MARKET SIZE (2020) 59
FIGURE 8 APPROACH 4: TOP-DOWN APPROACH 59
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE LATERAL FLOW ASSAYS MARKET (2020) 61
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 62
FIGURE 10 DATA TRIANGULATION METHODOLOGY 62
2.4 KEY INDUSTRY INSIGHTS 63
2.5 LIMITATIONS 63
2.5.1 METHODOLOGY-RELATED LIMITATIONS 63
2.6 RISK ASSESSMENT 64
2.7 ASSUMPTIONS FOR THE STUDY 64
3 EXECUTIVE SUMMARY 65
FIGURE 11 LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 65
FIGURE 12 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,
2021 VS. 2026 (USD MILLION) 66
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 66
FIGURE 14 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2021 VS. 2026 (USD MILLION) 67
FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 68
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET 69
4 PREMIUM INSIGHTS 70
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW 70
FIGURE 17 RISING COVID-19 PATIENT POPULATION AND GROWTH IN THE PREVALENCE OF INFECTIOUS DISEASES ARE DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET 70
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET 71
FIGURE 18 APAC TO REGISTER THE HIGHEST CAGR OF 5.8% DURING THE FORECAST PERIOD 71
4.3 ASIA PACIFIC LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY 72
FIGURE 19 CLINICAL TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN
ASIA PACIFIC 72
4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 73
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATES DURING THE FORECAST PERIOD 73
4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPING VS DEVELOPED COUNTRIES 73
FIGURE 21 DEVELOPING COUNTRIES TO OFFER HIGHER GROWTH 73
5 MARKET OVERVIEW 74
5.1 INTRODUCTION 74
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 74
5.2.1 DRIVERS 75
5.2.1.1 High prevalence of infectious diseases across the globe 75
FIGURE 22 PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE 75
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2020) 76
5.2.1.2 Rapidly increasing geriatric population 76
FIGURE 23 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION) 77
FIGURE 24 GERIATRIC POPULATION, BY COUNTRY, 2020 VS. 2060 (MILLION) 77
5.2.1.3 Growing usage of home-based lateral flow assay devices 78
5.2.1.4 Growing demand for point-of-care testing 78
5.2.1.5 Need for rapid diagnostic testing for COVID-19 79
FIGURE 25 NUMBER OF CONFIRMED CASES OF COVID-19, BY WHO REGION (MILLION) 79
5.2.2 RESTRAINTS 80
5.2.2.1 Inconsistent results of lateral flow assay tests 80
5.2.3 OPPORTUNITIES 80
5.2.3.1 Evolving applications of lateral flow assays 80
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS 81
5.2.3.2 Rising demand for lateral flow assays in the food & beverage industry 81
5.2.4 CHALLENGES 82
5.2.4.1 Limited reimbursements for lateral flow assay products 82
5.2.4.2 Difficulties in procuring quality raw materials for the development of lateral flow assay tests 82
5.3 COVID-19 ECONOMIC ASSESSMENT 83
5.4 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 83
FIGURE 26 CRITERIA IMPACTING THE GLOBAL ECONOMY 83
5.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAYS MARKET 84
5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN LATERAL FLOW ASSAYS MARKET 85
FIGURE 27 YC–YCC SHIFT IN LATERAL FLOW ASSAYS MARKET 85
5.7 AVERAGE SELLING PRICE TREND 85
TABLE 4 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 86
TABLE 5 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS) 86
5.8 ECOSYSTEM MARKET MAP 87
FIGURE 28 ECOSYSTEM: LATERAL FLOW ASSAYS MARKET (2020) 87
5.9 PATENT ANALYSIS 88
5.9.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAY 88
FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAYS MARKET, 2016-2021 89
5.9.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAYS PATENTS 89
FIGURE 30 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAYS PATENTS, 2016–2021 89
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET 90
FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS PATENTS, 2016–2021 90
5.10 VALUE CHAIN ANALYSIS 90
FIGURE 32 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2020) 91
5.11 TECHNOLOGY ANALYSIS 91
5.11.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 91
5.11.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS) 91
5.12 CASE STUDY ANALYSIS 92
5.13 REGULATORY LANDSCAPE 93
TABLE 6 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 93
5.13.1 NORTH AMERICA 93
5.13.2 EUROPE 94
5.13.3 ASIA 94
5.13.3.1 India 94
5.13.3.2 China 95
5.13.3.3 Japan 95
5.14 PORTER’S FIVE FORCES ANALYSIS 95
TABLE 7 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 95
5.14.1 THREAT FROM NEW ENTRANTS 96
5.14.2 THREAT FROM SUBSTITUTES 97
5.14.3 BARGAINING POWER OF SUPPLIERS 97
5.14.4 BARGAINING POWER OF BUYERS 97
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.15 ADJACENT MARKET ANALYSIS 98
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 99
6.1 INTRODUCTION 100
TABLE 8 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 100
6.2 KITS & REAGENTS 100
6.2.1 INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS & REAGENTS IN THE LATERAL FLOW ASSAYS MARKET 100
TABLE 9 LATERAL FLOW KITS & REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
6.3 LATERAL FLOW ASSAYS READERS MARKET 102
TABLE 10 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN THE MARKET 102
TABLE 11 LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS 103
TABLE 12 LATERAL FLOW READERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 13 LATERAL FLOW READERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 104
TABLE 14 LATERAL FLOW READERS MARKET, BY END USER,
2019–2026 (USD MILLION) 104
TABLE 15 LATERAL FLOW READERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
6.3.1 DIGITAL/HANDHELD READERS 105
6.3.1.1 Technological advancements and high accuracy are the major factors driving the growth of the digital/handheld readers market 105
TABLE 16 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 106
TABLE 17 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 107
6.3.2 BENCHTOP READERS 107
6.3.2.1 Lower diagnosis cost per patient is driving the benchtop readers market 107
TABLE 18 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
TABLE 19 BENCHTOP LATERAL FLOW READERS VOLUME, REGION,
2019–2026 (THOUSAND UNITS) 108
6.4 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS 109
6.5 LATERAL FLOW ASSAYS READERS MARKETS FOR CLINICAL DIAGNOSTICS APPLICATIONS, BY TYPE 109
6.5.1 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS APPLICATION 109
TABLE 20 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS APPLICATION 109
FIGURE 33 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW ASSAYS READERS FOR CLINICAL DIAGNOSTICS (2020) 111
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 112
7.1 INTRODUCTION 113
TABLE 21 LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 113
7.2 CLINICAL TESTING 113
TABLE 22 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 23 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 114
7.2.1 INFECTIOUS DISEASE TESTING 115
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 115
TABLE 25 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 116
7.2.1.1 Mosquito-borne diseases 116
7.2.1.1.1 Increasing incidence of dengue is driving the growth of
the lateral flow assays market for mosquito-borne diseases 116
TABLE 26 MAJOR PRODUCTS: DENGUE TESTING 117
TABLE 27 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 118
7.2.1.2 COVID-19 118
7.2.1.2.1 The ongoing COVID-19 pandemic to drive the demand for rapid lateral flow tests 118
TABLE 28 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS 119
TABLE 29 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY,
2019–2026 (USD MILLION) 120
7.2.1.3 Influenza 120
7.2.1.3.1 Growing prevalence of influenza globally is expected to boost market growth 120
TABLE 30 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY,
2019–2026 (USD MILLION) 121
7.2.1.4 Sexually transmitted infections 121
TABLE 31 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2019–2026 (USD MILLION) 123
7.2.1.4.1 HIV 123
7.2.1.4.1.1 Growing awareness about HIV POC testing is one of
the major factors driving market growth 123
TABLE 33 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.2.1.4.2 HPV 124
7.2.1.4.2.1 Rising adoption of HPV testing to drive the market during the forecast period 124
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.2.1.4.3 Chlamydia 126
7.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients drive market growth 126
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2019–2026 126
7.2.1.4.4 Gonorrhea 127
7.2.1.4.4.1 Rising incidence of gonorrhea globally and increased funding for R&D to drive the lateral flow assays market during the forecast period 127
TABLE 36 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY,
2019–2026 (USD MILLION) 128
7.2.1.4.5 Syphilis 128
7.2.1.4.5.1 Growing adoption of novel technologies supporting the growth of the lateral flow assays market for syphilis testing 128
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.2.1.4.6 Other sexually transmitted infections 130
TABLE 38 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2019–2026 (USD MILLION) 130
7.2.1.5 Hepatitis 130
7.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in the hepatitis testing market 130
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY,
2019–2026 (USD MILLION) 131
7.2.1.6 Tuberculosis 132
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment drive the market 132
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY,
2019–2026 (USD MILLION) 132
7.2.1.7 Other infectious diseases 133
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES,
BY COUNTRY, 2019–2026 (USD MILLION) 133
7.2.2 CARDIAC MARKER TESTING 134
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 135
7.2.2.1 Troponin I & T 135
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive this market during the forecast period 135
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 136
7.2.2.2 CK-MB 136
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive this market 136
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY,
2019–2026 (USD MILLION) 137
7.2.2.3 BNP and NT-proBNP 137
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth in this market 137
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 138
7.2.2.4 Myoglobin 138
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict the growth of the routine myoglobin testing market 138
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 139
7.2.2.5 D-Dimer 139
7.2.2.5.1 Rising incidence of cardiovascular diseases to drive
the market for D-dimer tests 139
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 140
7.2.2.6 Other cardiac markers 140
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS,
BY COUNTRY, 2019–2026 (USD MILLION) 141
7.2.3 PREGNANCY & FERTILITY TESTING 141
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,
BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 142
7.2.3.1 Pregnancy testing 143
7.2.3.1.1 Pregnancy testing is among the most common application areas for lateral flow assays, registering slower growth during the forecast period 143
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 143
7.2.3.2 Fertility testing 144
7.2.3.2.1 Rising infertility rates across the globe driving the demand for POC fertility testing kits 144
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 144
7.2.4 CHOLESTEROL/LIPID TESTING 145
7.2.4.1 Growing prevalence of obesity and CVD is the key factor driving market growth 145
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 145
7.2.5 DRUGS-OF-ABUSE TESTING 146
7.2.5.1 Technological advancements and growing focus on workplace drug testing are driving market growth 146
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING,
BY COUNTRY, 2019–2026 (USD MILLION) 147
7.2.6 OTHER CLINICAL TESTS 147
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2019–2026 (USD MILLION) 148
7.3 VETERINARY DIAGNOSTICS 148
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 148
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,
BY COUNTRY, 2019–2026 (USD MILLION) 149
7.4 FOOD SAFETY & ENVIRONMENT TESTING 149
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 149
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 150
7.5 DRUG DEVELOPMENT & QUALITY TESTING 151
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET 151
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 151
8 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE 152
8.1 INTRODUCTION 153
TABLE 60 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE,
2019–2026 (USD MILLION) 153
8.2 SANDWICH ASSAYS 153
8.2.1 WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTE TO THE LARGEST SHARE OF THIS SEGMENT 153
TABLE 61 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 154
8.3 COMPETITIVE ASSAYS 155
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER GROWTH 155
TABLE 62 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 155
8.4 MULTIPLEX DETECTION ASSAYS 156
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET 156
TABLE 63 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
9 LATERAL FLOW ASSAYS FOR CLINICAL TESTING MARKET, BY SAMPLE TYPE 157
9.1 INTRODUCTION 158
TABLE 64 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 158
9.2 BLOOD SAMPLES 158
9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE THE GROWTH OF THIS SEGMENT 158
TABLE 65 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY,
2019–2026 (USD MILLION) 159
9.3 URINE SAMPLES 159
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY TESTING AND DRUGS-OF-ABUSE TESTING TO DRIVE THE GROWTH OF THIS MARKET 159
TABLE 66 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY,
2019–2026 (USD MILLION) 160
9.4 SALIVA SAMPLES 160
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES ARE THE KEY FACTORS DRIVING MARKET GROWTH 160
TABLE 67 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY,
2019–2026 (USD MILLION) 161
9.5 OTHER SAMPLES 161
TABLE 68 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,
BY COUNTRY, 2019–2026 (USD MILLION) 162
10 LATERAL FLOW ASSAYS MARKET, BY END USER 163
10.1 INTRODUCTION 164
TABLE 69 LATERAL FLOW ASSAYS MARKET, BY END USER, 2019–2026 (USD MILLION) 164
10.2 HOSPITALS & CLINICS 164
10.2.1 INCREASING USE OF POC TESTS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS 164
TABLE 70 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 165
10.3 DIAGNOSTIC LABORATORIES 165
10.3.1 LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING—A KEY FACTOR DRIVING MARKET GROWTH 165
TABLE 71 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2019–2026 (USD MILLION) 166
10.4 HOME CARE SETTINGS 166
10.4.1 GROWING ACCEPTANCE OF REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE 166
TABLE 72 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION) 167
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 167
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE THE USE OF LATERAL FLOW ASSAYS AMONG PHARMACEUTICAL & BIOTECH COMPANIES 167
TABLE 73 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 168
10.6 OTHER END USERS 168
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 169
11 LATERAL FLOW ASSAYS MARKET, BY REGION 170
11.1 INTRODUCTION 171
FIGURE 34 US TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD 171
TABLE 75 LATERAL FLOW ASSAYS MARKET, BY REGION, 2019–2026 (USD MILLION) 172
11.2 NORTH AMERICA 173
TABLE 76 NORTH AMERICA: MACROECONOMIC INDICATORS 173
FIGURE 35 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 174
TABLE 77 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 175
TABLE 78 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 175
TABLE 79 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 176
TABLE 81 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 82 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 177
TABLE 83 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 84 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 86 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2019–2026 (USD MILLION) 179
TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 179
TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 180
11.2.1 US 180
11.2.1.1 The US accounts for the largest share of the lateral flow assays market in North America 180
TABLE 89 US: MACROECONOMIC INDICATORS 181
TABLE 90 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 181
TABLE 91 US: LATERAL FLOW READERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 92 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 182
TABLE 93 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 94 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 183
TABLE 95 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 96 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 97 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 98 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 184
TABLE 99 US: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 185
TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 USD MILLION) 185
11.2.2 CANADA 185
11.2.2.1 Availability of research funding and implementation of favorable government initiatives are driving the market in Canada 185
TABLE 101 CANADA: MACROECONOMIC INDICATORS 186
TABLE 102 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 186
TABLE 103 CANADA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 104 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 187
TABLE 105 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 106 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 188
TABLE 107 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 108 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 109 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 110 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 190
TABLE 111 CANADA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 190
TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 191
11.3 EUROPE 191
FIGURE 36 EUROPE: LATERAL FLOW ASSAYS MARKET SNAPSHOT 192
TABLE 113 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 193
TABLE 114 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 193
TABLE 115 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 116 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 194
TABLE 117 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 195
TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 120 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 121 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 122 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 196
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 197
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 197
11.3.1 GERMANY 197
11.3.1.1 Growing number of POC diagnostics centers to drive the demand for lateral flow assays in Germany 197
TABLE 125 GERMANY: MACROECONOMIC INDICATORS 198
TABLE 126 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 198
TABLE 127 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 128 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 199
TABLE 129 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 130 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 200
TABLE 131 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 132 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 133 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 134 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2019–2026 (USD MILLION) 201
TABLE 135 GERMANY: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 202
TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 202
11.3.2 FRANCE 202
11.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 202
TABLE 137 FRANCE: MACROECONOMIC INDICATORS 203
TABLE 138 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 139 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 140 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 204
TABLE 141 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 142 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 205
TABLE 143 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 144 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 145 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 146 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 206
TABLE 147 FRANCE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 207
TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 207
11.3.3 UK 207
11.3.3.1 Increasing incidence of chronic diseases and rising prevalence of obesity propelling the market growth in the UK 207
TABLE 149 UK: MACROECONOMIC INDICATORS 208
TABLE 150 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 208
TABLE 151 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 152 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 209
TABLE 153 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 154 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 210
TABLE 155 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 156 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 157 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 158 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 212
TABLE 159 UK: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 212
TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 213
11.3.4 ITALY 213
11.3.4.1 Growing initiatives towards the decentralization of medical services in Italy are contributing to market growth 213
TABLE 161 ITALY: MACROECONOMIC INDICATORS 213
TABLE 162 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 214
TABLE 163 ITALY: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 164 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 215
TABLE 165 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 166 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 216
TABLE 167 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 168 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 169 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 170 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 217
TABLE 171 ITALY: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 218
TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 218
11.3.5 SPAIN 218
11.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 218
TABLE 173 SPAIN: MACROECONOMIC INDICATORS 219
TABLE 174 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 219
TABLE 175 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 176 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 220
TABLE 177 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 178 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 221
TABLE 179 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 180 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 181 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 182 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 222
TABLE 183 SPAIN: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 223
TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 223
11.3.6 REST OF EUROPE 223
TABLE 185 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 224
TABLE 186 ROE: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 187 ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 224
TABLE 188 ROE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 189 ROE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,
BY DISEASE TYPE, 2019–2026 (USD MILLION) 225
TABLE 190 ROE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 191 ROE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 192 ROE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 193 ROE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 227
TABLE 194 ROE: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 227
TABLE 195 ROE: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 228
11.4 ASIA PACIFIC 228
FIGURE 37 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT 229
TABLE 196 APAC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 230
TABLE 197 APAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 198 APAC: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 199 APAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 231
TABLE 200 APAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 201 APAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 232
TABLE 202 APAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 232
TABLE 203 APAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 233
TABLE 204 APAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 233
TABLE 205 APAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 233
TABLE 206 APAC: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 234
TABLE 207 APAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 234
11.4.1 JAPAN 234
11.4.1.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assays market in Japan 234
TABLE 208 JAPAN: MACROECONOMIC INDICATORS 235
TABLE 209 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 235
TABLE 210 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 236
TABLE 211 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 236
TABLE 212 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 237
TABLE 213 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 237
TABLE 214 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 238
TABLE 215 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 238
TABLE 216 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 239
TABLE 217 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 239
TABLE 218 JAPAN: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 239
TABLE 219 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 240
11.4.2 CHINA 240
11.4.2.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development is expected to drive market growth in China 240
TABLE 220 CHINA: MACROECONOMIC INDICATORS 241
TABLE 221 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 241
TABLE 222 CHINA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 241
TABLE 223 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 242
TABLE 224 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 242
TABLE 225 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 243
TABLE 226 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 243
TABLE 227 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 244
TABLE 228 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 244
TABLE 229 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 244
TABLE 230 CHINA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 245
TABLE 231 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 245
11.4.3 INDIA 245
11.4.3.1 Increasing prevalence of chronic disorders, growing healthcare concerns, and rising income levels to propel the growth of this market 245
TABLE 232 INDIA: MACROECONOMIC INDICATORS 246
TABLE 233 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 246
TABLE 234 INDIA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 235 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 247
TABLE 236 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 247
TABLE 237 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 248
TABLE 238 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 248
TABLE 239 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 240 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 249
TABLE 241 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 249
TABLE 242 INDIA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 250
TABLE 243 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 250
11.4.4 AUSTRALIA 250
11.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assays market 250
TABLE 244 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 251
TABLE 245 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 251
TABLE 246 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 251
TABLE 247 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 248 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 252
TABLE 249 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 250 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 253
TABLE 251 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 254
TABLE 252 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2019–2026 (USD MILLION) 254
TABLE 253 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 254
TABLE 254 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 255
11.4.5 REST OF ASIA PACIFIC 255
TABLE 255 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 255
TABLE 256 ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 256
TABLE 257 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 256
TABLE 258 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 257
TABLE 259 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 257
TABLE 260 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 258
TABLE 261 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 258
TABLE 262 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 263 ROAPAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 259
TABLE 264 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 259
TABLE 265 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 260
11.5 LATIN AMERICA 260
TABLE 266 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 260
TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 261
TABLE 268 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 261
TABLE 269 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 261
TABLE 270 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 262
TABLE 271 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 262
TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 263
TABLE 273 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 263
TABLE 274 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 264
TABLE 275 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,
BY TECHNIQUE, 2019–2026 (USD MILLION) 264
TABLE 276 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 264
TABLE 277 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 265
11.5.1 BRAZIL 265
11.5.1.1 High private healthcare expenditure and increasing geriatric population driving the growth of the lateral flow assays market in
the country 265
TABLE 278 BRAZIL: MACROECONOMIC INDICATORS 265
TABLE 279 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 266
TABLE 280 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 266
TABLE 281 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 266
TABLE 282 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 267
TABLE 283 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 267
TABLE 284 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 285 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,
BY TYPE, 2019–2026 (USD MILLION) 268
TABLE 286 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 269
TABLE 287 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 269
TABLE 288 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 269
TABLE 289 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 270
11.5.2 MEXICO 270
11.5.2.1 High prevalence of obesity and related chronic diseases to boost the growth of the lateral flow assays market in the forecast period 270
TABLE 290 MEXICO: MACROECONOMIC INDICATORS 271
TABLE 291 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 271
TABLE 292 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 271
TABLE 293 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 272
TABLE 294 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 272
TABLE 295 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 273
TABLE 296 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 273
TABLE 297 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 274
TABLE 298 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 274
TABLE 299 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 274
TABLE 300 MEXICO: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 275
TABLE 301 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 275
11.5.3 REST OF LATIN AMERICA 275
TABLE 302 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 276
TABLE 303 ROLATAM: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 276
TABLE 304 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 276
TABLE 305 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 277
TABLE 306 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 277
TABLE 307 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 278
TABLE 308 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2019–2026 (USD MILLION) 278
TABLE 309 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 279
TABLE 310 ROLATAM: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 279
TABLE 311 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,
2019–2026 (USD MILLION) 279
TABLE 312 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY END USER,
2019–2026 (USD MILLION) 280
11.6 MIDDLE EAST & AFRICA 280
11.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANSION OF HEALTHCARE SERVICES IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS 280
TABLE 313 AFRICA: MACROECONOMIC INDICATORS 281
TABLE 314 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 281
TABLE 315 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 281
TABLE 316 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 282
TABLE 317 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 282
TABLE 318 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2019–2026 (USD MILLION) 283
TABLE 319 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2019–2026 (USD MILLION) 283
TABLE 320 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2029–2026 (USD MILLION) 284
TABLE 321 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2019–2026 (USD MILLION) 284
TABLE 322 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 284
TABLE 323 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2019–2026 (USD MILLION) 285
TABLE 324 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2019–2026 (USD MILLION) 285
12 COMPETITIVE LANDSCAPE 286
12.1 OVERVIEW 286
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 286
FIGURE 38 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET 287
12.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAYS MARKET 288
FIGURE 39 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS IN THE LATERAL FLOW ASSAYS MARKET 288
12.4 MARKET SHARE ANALYSIS 289
FIGURE 40 LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2020) 289
TABLE 325 LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION 290
12.5 R&D ASSESSMENT OF KEY PLAYERS 291
FIGURE 41 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET, 2018 VS. 2020 291
12.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 292
FIGURE 42 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAYS MARKET (2020) 292
12.7 COMPANY EVALUATION QUADRANT 293
12.7.1 STARS 293
12.7.2 PERVASIVE PLAYERS 293
12.7.3 EMERGING LEADERS 293
12.7.4 PARTICIPANTS 293
FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2020 294
12.8 COMPANY EVALUATION QUADRANT FOR SMES & START-UPS 295
12.8.1 PROGRESSIVE COMPANIES 295
12.8.2 DYNAMIC COMPANIES 295
12.8.3 STARTING BLOCKS 295
12.8.4 RESPONSIVE COMPANIES 295
FIGURE 44 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR SMES & START-UPS 296
12.9 COMPETITIVE BENCHMARKING 297
12.9.1 OVERALL COMPANY FOOTPRINT 297
TABLE 326 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 297
TABLE 327 COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES) 298
TABLE 328 COMPANY FOOTPRINT: BY TECHNIQUE (25 COMPANIES) 299
TABLE 329 COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES) 300
TABLE 330 COMPANY FOOTPRINT: BY SAMPLE TYPE (25 COMPANIES) 301
TABLE 331 COMPANY FOOTPRINT: BY END USER (25 COMPANIES) 302
TABLE 332 COMPANY FOOTPRINT: BY REGION (25 COMPANIES) 303
12.10 COMPETITIVE SCENARIO 304
12.10.1 PRODUCT LAUNCHES & APPROVALS 304
TABLE 333 PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–SEPTEMBER 2021 304
12.10.2 DEALS 305
TABLE 334 DEALS, JANUARY 2018–SEPTEMBER 2021 305
12.10.3 EXPANSIONS 305
TABLE 335 EXPANSIONS, JANUARY 2018–SEPTEMBER 2021 305
13 COMPANY PROFILES 306
13.1 KEY PLAYERS 306
(Business overview, Solutions offered, Recent developments, COVID-19 Related developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats)*
13.1.1 ABBOTT LABORATORIES 306
TABLE 336 ABBOTT LABORATORIES: BUSINESS OVERVIEW 306
FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020) 307
13.1.2 F. HOFFMANN-LA ROCHE AG 314
TABLE 337 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW 314
FIGURE 46 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2020) 315
13.1.3 QUIDEL CORPORATION 319
TABLE 338 QUIDEL CORPORATION: BUSINESS OVERVIEW 319
FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020) 320
13.1.4 DANAHER CORPORATION 324
TABLE 339 DANAHER CORPORATION: BUSINESS OVERVIEW 324
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 325
13.1.5 SIEMENS AG 329
TABLE 340 SIEMENS AG: BUSINESS OVERVIEW 329
FIGURE 49 SIEMENS AG: COMPANY SNAPSHOT (2020) 330
13.1.6 BECTON, DICKINSON AND COMPANY 333
TABLE 341 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 333
FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 334
13.1.7 BIOMÉRIEUX SA 338
TABLE 342 BIOMERIEUX SA: BUSINESS OVERVIEW 338
FIGURE 51 BIOMERIEUX SA: COMPANY SNAPSHOT (2020) 339
13.1.8 BIO-RAD LABORATORIES, INC. 343
TABLE 343 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 343
FIGURE 52 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 344
13.1.9 THERMO FISHER SCIENTIFIC INC. 346
TABLE 344 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 346
FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020) 347
13.1.10 PERKINELMER INC. 350
TABLE 345 PERKINELMER, INC.: BUSINESS OVERVIEW 350
FIGURE 54 PERKINELMER, INC.: COMPANY SNAPSHOT (2020) 351
13.2 OTHER PLAYERS 354
13.2.1 QIAGEN N.V. 354
TABLE 346 QIAGEN N. V.: BUSINESS OVERVIEW 354
FIGURE 55 QIAGEN N. V.: COMPANY SNAPSHOT (2020) 355
13.2.2 MERCK KGAA 357
TABLE 347 MERCK KGAA: BUSINESS OVERVIEW 357
FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT (2020) 357
13.2.3 HOLOGIC, INC. 359
TABLE 348 HOLOGIC, INC.: BUSINESS OVERVIEW 359
FIGURE 57 HOLOGIC, INC.: COMPANY SNAPSHOT (2020) 360
13.2.4 ABCAM PLC 362
TABLE 349 ABCAM PLC: BUSINESS OVERVIEW 362
FIGURE 58 ABCAM PLC.: COMPANY SNAPSHOT (2020) 363
13.2.5 SURMODICS IVD 365
TABLE 350 SURMODICS IVD: BUSINESS OVERVIEW 365
FIGURE 59 SURMODICS IVD.: COMPANY SNAPSHOT (2020) 365
13.2.6 CHEMBIO DIAGNOSTIC SYSTEMS, INC. 367
TABLE 351 CHEMBIO DIAGNOSTICS SYSTEMS: BUSINESS OVERVIEW 367
FIGURE 60 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: COMPANY SNAPSHOT (2020) 367
13.2.7 ORASURE TECHNOLOGIES 370
TABLE 352 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW 370
FIGURE 61 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2020) 371
13.2.8 DCN DIAGNOSTICS 373
TABLE 353 DCN DIAGNOSTICS: BUSINESS OVERVIEW 373
13.2.9 POLYSCIENCES, INC. 374
TABLE 354 POLYSCIENCES, INC.: BUSINESS OVERVIEW 374
13.2.10 ABINGDON HEALTH 375
TABLE 355 ABINGDON HEALTH: BUSINESS OVERVIEW 375
13.2.11 BIOPORTO DIAGNOSTICS A/S 376
TABLE 356 BIOPORTO DIAGNOSTICS A/S: BUSINESS OVERVIEW 376
FIGURE 62 BIOPORTO DIAGNOSTICS A/S: COMPANY SNAPSHOT (2020) 376
13.2.12 MICROCOAT BIOTECHNOLOGIES GMBH 378
TABLE 357 MICROCOAT BIOTECHNOLOGIES GMBH: BUSINESS OVERVIEW 378
13.2.13 SCIENION AG 379
TABLE 358 SCIENION AG: BUSINESS OVERVIEW 379
13.2.14 SENOVA GMBH 380
TABLE 359 SENOVA GMBH: BUSINESS OVERVIEW 380
13.2.15 ACCESS BIO, INC. 381
TABLE 360 ACCESS BIO, INC.: BUSINESS OVERVIEW 381
*Business overview, Solutions offered, Recent developments, COVID-19 Related developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
14 APPENDIX 382
14.1 DISCUSSION GUIDE 382
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 387
14.3 AVAILABLE CUSTOMIZATIONS 389
14.4 RELATED REPORTS 389
14.5 AUTHOR DETAILS 390
